Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer

Chedgy, Edmund C. P.; Douglas, James; Wright, Jonathan L.; Seiler, Roland; van Rhijn, Bas W. G.; Boormans, Joost; Dinney, Colin P.; Collins, Colin C.; Van der Heijden, Michiel S.; Black, Peter C.; Todenhöfer, Tilman

dc.contributor.author	Todenhöfer, Tilman Wolfgang
dc.date.accessioned	2018-11-12T12:10:18Z
dc.date.available	2018-11-12T12:10:18Z
dc.date.issued	2016
dc.identifier.issn	1873-2496
dc.identifier.uri	http://hdl.handle.net/10900/84743
dc.language.iso	en	de_DE
dc.publisher	Elsevier Science Inc	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.urolonc.2016.05.012	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20180405102126_00778
utue.publikation.seiten	469-476	de_DE
utue.personen.roh	Chedgy, Edmund C. P.
utue.personen.roh	Douglas, James
utue.personen.roh	Wright, Jonathan L.
utue.personen.roh	Seiler, Roland
utue.personen.roh	van Rhijn, Bas W. G.
utue.personen.roh	Boormans, Joost
utue.personen.roh	Dinney, Colin P.
utue.personen.roh	Collins, Colin C.
utue.personen.roh	Van der Heijden, Michiel S.
utue.personen.roh	Black, Peter C.
utue.personen.roh	Todenhöfer, Tilman
dcterms.isPartOf.ZSTitelID	Urologic Oncology - Seminars and Original Investigations	de_DE
dcterms.isPartOf.ZS-Issue	10	de_DE
dcterms.isPartOf.ZS-Volume	34	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE